Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2016 1
2019 2
2020 2
2021 3
2022 5
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Apixaban for the Treatment of Venous Thromboembolism Associated with Cancer.
Agnelli G, Becattini C, Meyer G, Muñoz A, Huisman MV, Connors JM, Cohen A, Bauersachs R, Brenner B, Torbicki A, Sueiro MR, Lambert C, Gussoni G, Campanini M, Fontanella A, Vescovo G, Verso M; Caravaggio Investigators. Agnelli G, et al. N Engl J Med. 2020 Apr 23;382(17):1599-1607. doi: 10.1056/NEJMoa1915103. Epub 2020 Mar 29. N Engl J Med. 2020. PMID: 32223112 Clinical Trial.
Thromboprophylaxis in Patients With Cancer and COVID-19.
Lecumberri R, Marcos-Jubilar M, Guillén C. Lecumberri R, et al. Among authors: marcos jubilar m. Arch Bronconeumol. 2022 Nov;58(11):744-745. doi: 10.1016/j.arbres.2022.08.006. Epub 2022 Sep 8. Arch Bronconeumol. 2022. PMID: 36153216 Free PMC article. No abstract available.
Obinutuzumab in follicular lymphoma.
Martinez-Calle N, Figueroa-Mora R, Villar-Fernandez S, Marcos-Jubilar M, Panizo C. Martinez-Calle N, et al. Among authors: marcos jubilar m. Drugs Today (Barc). 2016 Dec;52(12):643-651. doi: 10.1358/dot.2016.52.12.2550578. Drugs Today (Barc). 2016. PMID: 28276536 Review.
Impact of the mutation profile on thrombotic risk in cancer patients.
Páramo JA, Marcos-Jubilar M, Lecumberri R. Páramo JA, et al. Among authors: marcos jubilar m. Rev Clin Esp (Barc). 2022 Feb;222(2):93-99. doi: 10.1016/j.rceng.2021.04.008. Epub 2021 Sep 20. Rev Clin Esp (Barc). 2022. PMID: 34548256 Review.
Factor XI inhibitors: A new era in antithrombotic therapy.
Páramo JA, Marcos-Jubilar M. Páramo JA, et al. Among authors: marcos jubilar m. Med Clin (Barc). 2024 Jan 26;162(2):73-76. doi: 10.1016/j.medcli.2023.09.003. Epub 2023 Oct 18. Med Clin (Barc). 2024. PMID: 37863734 English, Spanish. No abstract available.
11C-Methionine PET/CT in Assessment of Multiple Myeloma Patients: Comparison to 18F-FDG PET/CT and Prognostic Value.
Morales-Lozano MI, Rodriguez-Otero P, Sancho L, Nuñez-Cordoba JM, Prieto E, Marcos-Jubilar M, Rosales JJ, Alfonso A, Guillen EF, San-Miguel J, Garcia-Velloso MJ. Morales-Lozano MI, et al. Among authors: marcos jubilar m. Int J Mol Sci. 2022 Aug 31;23(17):9895. doi: 10.3390/ijms23179895. Int J Mol Sci. 2022. PMID: 36077292 Free PMC article.
Analysis of common biomarkers in capillary blood in routine clinical laboratory. Preanalytical and analytical comparison with venous blood.
Maroto-García J, Deza S, Fuentes-Bullejos P, Fernández-Tomás P, Martínez-Espartosa D, Marcos-Jubilar M, Varo N, González Á. Maroto-García J, et al. Among authors: marcos jubilar m. Diagnosis (Berl). 2023 Mar 7;10(3):281-297. doi: 10.1515/dx-2022-0126. eCollection 2023 Aug 1. Diagnosis (Berl). 2023. PMID: 36877154
Analysis of monocitary subpopulations in relation to cardiovascular risk factors.
Marcos Jubilar M, Orbe J, Roncal C, Fernández Montero A, Colina I, Rodil R, Rodriguez JA, Zabaleta A, Paiva B, Pastrana JC, Páramo JA. Marcos Jubilar M, et al. Clin Investig Arterioscler. 2019 Jul-Aug;31(4):152-159. doi: 10.1016/j.arteri.2019.02.003. Epub 2019 Apr 6. Clin Investig Arterioscler. 2019. PMID: 30967277 English, Spanish.
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TC.
Bailén R, Pascual-Cascón MJ, Guerreiro M, López-Corral L, Chinea A, Bermúdez A, Sampol A, Heras I, García-Torres E, Torres M, Roca JR, Herruzo B, Sanz J, Fonseca M, Herrera P, Colorado M, Bento L, López-Godino O, Martín-Calvo C, Fernández-Caldas P, Marcos-Jubilar M, Sánchez-Ortega I, Solano C, Noriega V, Humala K, Oarbeascoa G, Díez-Martín JL, Kwon M; Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH). Bailén R, et al. Among authors: marcos jubilar m. Transplant Cell Ther. 2022 Apr;28(4):204.e1-204.e10. doi: 10.1016/j.jtct.2022.01.020. Epub 2022 Jan 31. Transplant Cell Ther. 2022. PMID: 35108627 Free article.
15 results